Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4868691
Max Phase: Preclinical
Molecular Formula: C39H51N4O7PS
Molecular Weight: 750.90
Molecule Type: Unknown
Associated Items:
ID: ALA4868691
Max Phase: Preclinical
Molecular Formula: C39H51N4O7PS
Molecular Weight: 750.90
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)OC(=O)[C@H](Cc1ccccc1)NP(=O)(COCCc1nc(N)sc1-c1ccc(OC(C)C)cc1)N[C@@H](Cc1ccccc1)C(=O)OC(C)C
Standard InChI: InChI=1S/C39H51N4O7PS/c1-26(2)48-32-19-17-31(18-20-32)36-33(41-39(40)52-36)21-22-47-25-51(46,42-34(37(44)49-27(3)4)23-29-13-9-7-10-14-29)43-35(38(45)50-28(5)6)24-30-15-11-8-12-16-30/h7-20,26-28,34-35H,21-25H2,1-6H3,(H2,40,41)(H2,42,43,46)/t34-,35-/m0/s1
Standard InChI Key: PFAHMNLXWUZXRT-PXLJZGITSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 750.90 | Molecular Weight (Monoisotopic): 750.3216 | AlogP: 7.19 | #Rotatable Bonds: 20 |
Polar Surface Area: 151.10 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.61 | CX Basic pKa: 4.63 | CX LogP: 6.54 | CX LogD: 6.54 |
Aromatic Rings: 4 | Heavy Atoms: 52 | QED Weighted: 0.05 | Np Likeness Score: -0.37 |
1. Břehová P, Chaloupecká E, Česnek M, Skácel J, Dračínský M, Tloušťová E, Mertlíková-Kaiserová H, Soto-Velasquez MP, Watts VJ, Janeba Z.. (2021) Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases., 222 [PMID:34102377] [10.1016/j.ejmech.2021.113581] |
Source(1):